ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Internal Medicine

Top Internal Medicine Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL SCOVNER MD

Internal Medicine

6,966

$444K

305
211 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $63

PAMELA PEDERSEN M.D,

Internal Medicine

6,702

$337K

259
174 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

16%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $63

FRANCIS LANDRY MD

Internal Medicine

6,455

$349K

335
292 are 65+

14%
patients receiving schedule two controlled substances

Avg: 10%

3%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $63

STEVEN SMITH MD

Internal Medicine

6,413

$398K

333
289 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $63

MARVIN KLIKUNAS MD

Internal Medicine

6,395

$431K

281
265 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $63

AUDREY VONLEPEL M.D.

Internal Medicine

6,387

$342K

252
189 are 65+

18%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $63

TIMOTHY TANNER MD

Internal Medicine

6,298

$394K

262
196 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

KEITH MICHL MD

Internal Medicine

6,154

$347K

378
345 are 65+

4%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $63

ANTHONY WILLIAMS MD, FACP

Internal Medicine

6,128

$316K

293
188 are 65+

14%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $63

ROGER FOX MD

Internal Medicine

5,757

$384K

393
343 are 65+

6%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $63

JOHN LEPPMAN MD

Internal Medicine

5,717

$268K

368
175 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $63

MARISA FRISCIA MD

Internal Medicine

5,603

$367K

200
167 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $63

LOUIS MEYERS M.D.

Internal Medicine

5,379

$328K

243
159 are 65+

19%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $63

ANNE BRENA MD

Internal Medicine

5,329

$408K

357
180 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$77
Average prescription price

Avg: $63

PRISCILLA CARR MD

Internal Medicine

5,279

$304K

215
181 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $63

RICHARD TONINO M.D.

Internal Medicine

5,279

$370K

434
386 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $63

JEFFREY STALL M.D.

Internal Medicine

5,219

$466K

205
127 are 65+

20%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$89
Average prescription price

Avg: $63

MARK PASANEN MD

Internal Medicine

5,204

$514K

328
174 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$99
Average prescription price

Avg: $63

JOHN WRIGHT M.D.

Internal Medicine

4,994

$290K

258
195 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $63

STEPHEN BAAD M.D.

Internal Medicine

4,985

$324K

320
243 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $63

JEFFREY RUBMAN M.D.

Internal Medicine

4,934

$281K

256
227 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $63

LAURA FELSTED DO

Internal Medicine

4,861

$257K

316
256 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $63

NAOMI HODDE MD

Internal Medicine

4,850

$317K

366
308 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

3%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $63

BARBARA MASLEY M.D.

Internal Medicine

4,787

$337K

315
184 are 65+

18%
patients receiving schedule two controlled substances

Avg: 10%

15%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $63

JOHN MATTHEW M.D.

Internal Medicine

4,727

$349K

198
120 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

15%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank